portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Beijing Tongrentang H1 Earnings Up 27.6%
 
CreateTime:2011-08-25     Source:CapitalVue Editor:xujintao
Text Size:       
 

August 24 -- Beijing Tongrentang (600085.SH) posted a 27.6 percent increase in net profit from the first half of 2011 to 259 million yuan, with earnings per share of 0.497 yuan, reports yicai.com, citing a company filing. Percentage changes cited in this report are year-on-year.

Revenue jumped 24.53 percent to 2.52 billion yuan during the reporting period. Specifically, earnings from traditional Chinese medicine (TCM) was 2.503 billion yuan.

The price of active pharmaceutical ingredient (API) of TCM rose 23.7 percent in the first half of 2011, according to data from zyctd.com. An expert from zyctd.com predicts the prices of API of TCM will fall 15-20 percent over the next two to three months. The output of commonly used APIs will rebound this year, while the prices of APIs with long growing periods, such as ginseng and pseudo-ginseng, will remain level.

Beijing Tongrentang said it was handling procedures regarding investment in Beijing Tongrentang Commercial Investment. It will inject assets of Tongrentang retail stores and equities of 23 retail stores into Beijing Tongrentang Commercial.


Related Reports
China Pharmaceutical Glass Packaging Industry Report, 2014-2017
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1